Search
Now showing items 1-1 of 1
Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer.
(
Elsevier
, 2019 , Article)
Neuroendocrine breast cancer (NEBC) is a group of rare tumors, which could benefit from therapy targeting the somatostatin receptors (SSTRs). In particular, SSTR2A and SSTR5 are potential targets given their consistent ...